Rare diseases
Investigational molecules
Locations
Back to Sweden376 clinical trials in Gothenburg, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants
SwedenA Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness
SwedenEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
SwedenPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
SwedenEfficacy and Safety of Atumelnant, Hydrocortisone and Prednisone in Adults with ACTH‑Dependent Cushing’s Syndrome: A Phase 2/3 Dose‑Finding Study
SwedenA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
SwedenA Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer
SwedenPhase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer
SwedenStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
SwedenReduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial
SwedenSwedenFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
SwedenThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on innovative treatments for various types of leukemia, including chronic lymphocytic leukemia and acute myeloid leukemia. Studies are evaluating new therapeutic combinations and treatment approaches for lymphoma and pediatric cancers.
Advanced research into targeted therapies and personalized treatment protocols for better patient outcomes.
Groundbreaking studies on rare genetic conditions including Niemann-Pick disease and gangliosidoses. Research focuses on evaluating novel treatments and investigating long-term outcomes for mucopolysaccharidosis and other rare disorders.
Innovative approaches to addressing complex rare diseases with targeted therapeutic interventions.
Comprehensive research into cardiovascular disease prevention and treatment, alongside studies on various kidney conditions. Trials evaluating new medications for stroke prevention in atrial fibrillation and treatments for glomerular diseases.
Focus on developing effective treatments for both common and rare cardiovascular and renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
